Fourier Intelligence
Fourier Intelligence was founded in 2015 and is headquartered in Shanghai (private). Fourier (上海傅利叶智能, formerly Fourier Intelligence), founded 2015 in Shanghai, began in rehabilitation robotics — exoskeletons and therapy systems in 2,000+ medical institutions — before the GRx humanoid series (GR-1 2023, GR-2 2024, GR-3 Care-bot 2025).
It raised ~$110M Series E in early 2025 plus $41.8M Series E3 (Aug 2025), and released the N1, described as China's first verified open-source humanoid, in early 2025.
Key Products & Indicative Prices
| Product | Indicative Price | Specs |
|---|---|---|
| GR-2 | n/a | 175 cm, 63 kg, 53 DoF, 12-DoF dexterous hands, detachable battery |
| GR-3 Care-bot | n/a | 165 cm, 55 DoF, soft-touch body, tactile sensing, 3 h runtime |
| N1 | n/a | Open-source humanoid platform for research/developers |
| RehabHub / exoskeletons | n/a | Neurorehabilitation robots and limb exoskeletons, clinical use |
What Sets Them Apart
A decade in rehabilitation robotics gives Fourier human-safe force control and clinical reliability that general-purpose humanoid makers lack — the basis of its 'Care-bot' positioning. Academic ties and NVIDIA Isaac Lab compatibility make GR a standard research testbed.
Recent Developments
- 2026-01 — GR-3 Care-bot made its US debut at CES 2026, demoing multimodal interaction for eldercare scenarios.
- 2025-08 — Closed $41.8M Series E3; N1 open-source humanoid released earlier in 2025.
Procurement Notes
Enterprise/research sales; humanoid pricing is quotation-only. Confirm export availability and lead times directly. MOQ: n/a.